Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
PLoS One ; 18(8): e0288000, 2023.
Article in English | MEDLINE | ID: mdl-37603575

ABSTRACT

Various methods have been developed to combine inference across multiple sets of results for unsupervised clustering, within the ensemble clustering literature. The approach of reporting results from one 'best' model out of several candidate clustering models generally ignores the uncertainty that arises from model selection, and results in inferences that are sensitive to the particular model and parameters chosen. Bayesian model averaging (BMA) is a popular approach for combining results across multiple models that offers some attractive benefits in this setting, including probabilistic interpretation of the combined cluster structure and quantification of model-based uncertainty. In this work we introduce clusterBMA, a method that enables weighted model averaging across results from multiple unsupervised clustering algorithms. We use clustering internal validation criteria to develop an approximation of the posterior model probability, used for weighting the results from each model. From a combined posterior similarity matrix representing a weighted average of the clustering solutions across models, we apply symmetric simplex matrix factorisation to calculate final probabilistic cluster allocations. In addition to outperforming other ensemble clustering methods on simulated data, clusterBMA offers unique features including probabilistic allocation to averaged clusters, combining allocation probabilities from 'hard' and 'soft' clustering algorithms, and measuring model-based uncertainty in averaged cluster allocation. This method is implemented in an accompanying R package of the same name. We use simulated datasets to explore the ability of the proposed technique to identify robust integrated clusters with varying levels of separation between subgroups, and with varying numbers of clusters between models. Benchmarking accuracy against four other ensemble methods previously demonstrated to be highly effective in the literature, clusterBMA matches or exceeds the performance of competing approaches under various conditions of dimensionality and cluster separation. clusterBMA substantially outperformed other ensemble methods for high dimensional simulated data with low cluster separation, with 1.16 to 7.12 times better performance as measured by the Adjusted Rand Index. We also explore the performance of this approach through a case study that aims to identify probabilistic clusters of individuals based on electroencephalography (EEG) data. In applied settings for clustering individuals based on health data, the features of probabilistic allocation and measurement of model-based uncertainty in averaged clusters are useful for clinical relevance and statistical communication.


Subject(s)
Algorithms , Benchmarking , Humans , Bayes Theorem , Clinical Relevance , Cluster Analysis
2.
Diabetes Res Clin Pract ; 203: 110865, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37536514

ABSTRACT

AIMS: To evaluate the long-term efficacy of high-frequency (10 kHz) spinal cord stimulation (SCS) for treating refractory painful diabetic neuropathy (PDN). METHODS: The SENZA-PDN study was a prospective, multicenter, randomized controlled trial that compared conventional medical management (CMM) alone with 10 kHz SCS plus CMM (10 kHz SCS+CMM) in 216 patients with refractory PDN. After 6 months, participants with insufficient pain relief could cross over to the other treatment. In total, 142 patients with a 10 kHz SCS system were followed for 24 months, including 84 initial 10 kHz SCS+CMM recipients and 58 crossovers from CMM alone. Assessments included pain intensity, health-related quality of life (HRQoL), sleep, and neurological function. Investigators assessed neurological function via sensory, reflex, and motor tests. They identified a clinically meaningful improvement relative to the baseline assessment if there was a significant persistent improvement in neurological function that impacted the participant's well-being and was attributable to a neurological finding. RESULTS: At 24 months, 10 kHz SCS reduced pain by a mean of 79.9% compared to baseline, with 90.1% of participants experiencing ≥50% pain relief. Participants had significantly improved HRQoL and sleep, and 65.7% demonstrated clinically meaningful neurological improvement. Five (3.2%) SCS systems were explanted due to infection. CONCLUSIONS: Over 24 months, 10 kHz SCS provided durable pain relief and significant improvements in HRQoL and sleep. Furthermore, the majority of participants demonstrated neurological improvement. These long-term data support 10 kHz SCS as a safe and highly effective therapy for PDN. TRIAL REGISTRATION: ClincalTrials.gov Identifier, NCT03228420.


Subject(s)
Diabetes Mellitus , Diabetic Neuropathies , Spinal Cord Stimulation , Humans , Spinal Cord Stimulation/methods , Diabetic Neuropathies/therapy , Quality of Life , Prospective Studies , Pain , Treatment Outcome
3.
Int J Sports Physiol Perform ; 18(11): 1269-1274, 2023 Nov 01.
Article in English | MEDLINE | ID: mdl-37487585

ABSTRACT

PURPOSE: To evaluate statistical models developed for predicting medal-winning performances for international swimming events and generate updated performance predictions for the Paris 2024 Olympic Games. METHODS: The performance of 2 statistical models developed for predicting international swimming performances was evaluated. The first model employed linear regression and forecasting to examine performance trends among medal winners, finalists, and semifinalists over an 8-year period. A machine-learning algorithm was used to generate time predictions for each individual event for the Paris 2024 Olympic Games. The second model was a Bayesian framework and comprised an autoregressive term (the previous winning time), moving average (past 3 events), and covariates for stroke, gender, distance, and type of event (World Championships vs Olympic Games). To examine the accuracy of the predictions from both models, the mean absolute error was determined between the predicted times for the Budapest 2022 World Championships and the actual results from said championships. RESULTS: The mean absolute error for prediction of swimming performances was 0.80% for the linear-regression machine-learning model and 0.85% for the Bayesian model. The predicted times and actual times from the Budapest 2022 World Championships were highly correlated (r = .99 for both approaches). CONCLUSIONS: These models, and associated predictions for swimming events at the Paris 2024 Olympic Games, provide an evidence-based performance framework for coaches, sport-science support staff, and athletes to develop and evaluate training plans, strategies, and tactics, as well as informing resource allocation to athletes, based on their potential for the Paris 2024 Olympic Games.


Subject(s)
Athletes , Swimming , Humans , Bayes Theorem , Paris , Linear Models
4.
Curr Opin Biotechnol ; 78: 102828, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36332340

ABSTRACT

Upstream continuous processing, or most commonly perfusion processing, for biopharmaceutical production, is emerging as a feasible and viable manufacturing approach. Development in production of recombinant therapeutic proteins as well as viral vectors, vaccines, and cell therapy products, has numerous research publications that came out in previous years. Recent research areas are in perfusion-operation strategies maximizing and controlling bioreactor cell density, adding feed solution designed to supplement basal medium feed stream, combining cell line engineering with bioreactor conditions such as hypoxia, and implementing online process monitoring of cell density by capacitance sensor and metabolites by Raman spectroscopy. Perfusion applications are not limited to production process alone but include other upstream areas where high cell density process is essential such as in cell bank preparation, N-1 seed bioreactor, and combination with intensified fed-batch production process. This review covers recent advances in continuous processing over the last two years for biopharmaceutical production.


Subject(s)
Batch Cell Culture Techniques , Biological Products , Cricetinae , Animals , Batch Cell Culture Techniques/methods , CHO Cells , Cricetulus , Bioreactors , Recombinant Proteins/metabolism
5.
PLoS One ; 17(10): e0272848, 2022.
Article in English | MEDLINE | ID: mdl-36264879

ABSTRACT

Comparison and classification of ball trajectories can provide insight to support coaches and players in analysing their plays or opposition plays. This is challenging due to the innate variability and uncertainty of ball trajectories in space and time. We propose a framework based on Dynamic Time Warping (DTW) to cluster, compare and characterise trajectories in relation to play outcomes. Seventy-two international women's basketball games were analysed, where features such as ball trajectory, possession time and possession outcome were recorded. DTW was used to quantify the alignment-adjusted distance between three dimensional (two spatial, one temporal) trajectories. This distance, along with final location for the play (usually the shot), was then used to cluster trajectories. These clusters supported the conventional wisdom of higher scoring rates for fast breaks, but also identified other contextual factors affecting scoring rate, including bias towards one side of the court. In addition, some high scoring rate clusters were associated with greater mean change in the direction of ball movement, supporting the notion of entropy affecting effectiveness. Coaches and other end users could use such a framework to help make better use of their time by honing in on groups of effective or problematic plays for manual video analysis, for both their team and when scouting opponent teams and suggests new predictors for machine learning to analyse and predict trajectory-based sports.


Subject(s)
Athletic Performance , Basketball , Humans , Female , Movement , Entropy , Machine Learning
6.
Ecol Evol ; 12(8): e9172, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35949537

ABSTRACT

In general, it is not feasible to collect enough empirical data to capture the entire range of processes that define a complex system, either intrinsically or when viewing the system from a different geographical or temporal perspective. In this context, an alternative approach is to consider model transferability, which is the act of translating a model built for one environment to another less well-known situation. Model transferability and adaptability may be extremely beneficial-approaches that aid in the reuse and adaption of models, particularly for sites with limited data, would benefit from widespread model uptake. Besides the reduced effort required to develop a model, data collection can be simplified when transferring a model to a different application context. The research presented in this paper focused on a case study to identify and implement guidelines for model adaptation. Our study adapted a general Dynamic Bayesian Networks (DBN) of a seagrass ecosystem to a new location where nodes were similar, but the conditional probability tables varied. We focused on two species of seagrass (Zostera noltei and Zostera marina) located in Arcachon Bay, France. Expert knowledge was used to complement peer-reviewed literature to identify which components needed adjustment including parameterization and quantification of the model and desired outcomes. We adopted both linguistic labels and scenario-based elicitation to elicit from experts the conditional probabilities used to quantify the DBN. Following the proposed guidelines, the model structure of the general DBN was retained, but the conditional probability tables were adapted for nodes that characterized the growth dynamics in Zostera spp. population located in Arcachon Bay, as well as the seasonal variation on their reproduction. Particular attention was paid to the light variable as it is a crucial driver of growth and physiology for seagrasses. Our guidelines provide a way to adapt a general DBN to specific ecosystems to maximize model reuse and minimize re-development effort. Especially important from a transferability perspective are guidelines for ecosystems with limited data, and how simulation and prior predictive approaches can be used in these contexts.

7.
Mayo Clin Proc Innov Qual Outcomes ; 6(4): 347-360, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35814185

ABSTRACT

Objective: To evaluate high-frequency (10-kHz) spinal cord stimulation (SCS) treatment in refractory painful diabetic neuropathy. Patients and Methods: A prospective, multicenter randomized controlled trial was conducted between Aug 28, 2017 and March 16, 2021, comparing conventional medical management (CMM) with 10-kHz SCS+CMM. The participants had hemoglobin A1c level of less than or equal to 10% and pain greater than or equal to 5 of 10 cm on visual analog scale, with painful diabetic neuropathy symptoms 12 months or more refractory to gabapentinoids and at least 1 other analgesic class. Assessments included measures of pain, neurologic function, and health-related quality of life (HRQoL) over 12 months with optional crossover at 6 months. Results: The participants were randomized 1:1 to CMM (n=103) or 10-kHz SCS+CMM (n=113). At 6 months, 77 of 95 (81%) CMM group participants opted for crossover, whereas none of the 10-kHz SCS group participants did so. At 12 months, the mean pain relief from baseline among participants implanted with 10-kHz SCS was 74.3% (95% CI, 70.1-78.5), and 121 of 142 (85%) participants were treatment responders (≥50% pain relief). Treatment with 10-kHz SCS improved HRQoL, including a mean improvement in the EuroQol 5-dimensional questionnaire index score of 0.136 (95% CI, 0.104-0.169). The participants also reported significantly less pain interference with sleep, mood, and daily activities. At 12 months, 131 of 142 (92%) participants were "satisfied" or "very satisfied" with the 10-kHz SCS treatment. Conclusion: The 10-kHz SCS treatment resulted in substantial pain relief and improvement in overall HRQoL 2.5- to 4.5-fold higher than the minimal clinically important difference. The outcomes were durable over 12 months and support 10-kHz SCS treatment in patients with refractory painful diabetic neuropathy. Trial registration: clincaltrials.gov Identifier: NCT03228420.

8.
Biol Psychol ; 173: 108403, 2022 09.
Article in English | MEDLINE | ID: mdl-35908602

ABSTRACT

INTRODUCTION: To better understand the relationships between neurophysiology, cognitive function and psychopathology risk in adolescence there is value in identifying data-driven subgroups based on measurements of brain activity and function, and then comparing cognition and mental health between such subgroups. METHODS: We developed a flexible and scaleable multi-stage analysis pipeline to identify data-driven clusters of 12-year-olds (M = 12.64, SD = 0.32) based on frequency characteristics calculated from resting state, eyes-closed electroencephalography (EEG) recordings. For this preliminary cross-sectional study, EEG data was collected from 59 individuals in the Longitudinal Adolescent Brain Study (LABS) being undertaken in Queensland, Australia. Applying multiple unsupervised clustering algorithms to these EEG features, we identified well-separated subgroups of individuals. To study patterns of difference in cognitive function and mental health symptoms between clusters, we applied Bayesian regression models to probabilistically identify differences in these measures between clusters. RESULTS: We identified 5 core clusters associated with distinct subtypes of resting state EEG frequency content. Bayesian models demonstrated substantial differences in psychological distress, sleep quality and cognitive function between clusters. By examining associations between neurophysiology and health measures across clusters, we have identified preliminary risk and protective profiles linked to EEG characteristics. CONCLUSION: This method provides the potential to identify neurophysiological subgroups of adolescents in the general population based on resting state EEG, and associated patterns of health and cognition that are not observed at the whole group level. This approach offers potential utility in clinical risk prediction for mental and cognitive health outcomes throughout adolescent development.


Subject(s)
Psychological Distress , Sleep Quality , Adolescent , Bayes Theorem , Brain/physiology , Cognition , Cross-Sectional Studies , Electroencephalography/methods , Humans
10.
J Sports Sci ; 40(1): 24-31, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34544331

ABSTRACT

To develop a statistical model of winning times for international swimming events with the aim of predicting winning time distributions and the probability of winning for the 2020 and 2024 Olympic Games. The data set included first and third place times from all individual swimming events from the Olympics and World Championships from 1990 to 2019. We compared different model formulations fitted with Bayesian inference to obtain predictive distributions; comparisons were based on mean percentage error in out-of-sample predictions of Olympics and World Championships winning swim times from 2011 to 2019. The Bayesian time series regression model, comprising auto-regressive and moving average terms and other predictors, had the smallest mean prediction error of 0.57% (CI 0.46-0.74%). For context, using the respective previous Olympics or World Championships winning time resulted in a mean prediction error of 0.70% (CI 0.59-0.82%). The Olympics were on average 0.5% (CI 0.3-0.7%) faster than World Championships over the study period. The model computes the posterior predictive distribution, which allows coaches and athletes to evaluate the probability of winning given an individual's swim time, and the probability of being faster or slower than the previous winning time or even the world record.


Subject(s)
Competitive Behavior , Swimming , Athletes , Bayes Theorem , Humans , Time Factors
11.
PLoS One ; 16(7): e0254538, 2021.
Article in English | MEDLINE | ID: mdl-34265006

ABSTRACT

AIM: The aim was to predict and understand variations in swimmer performance between individual and relay events, and develop a predictive model for the 4x200-m swimming freestyle relay event to help inform team selection and strategy. DATA AND METHODS: Race data for 716 relay finals (4 x 200-m freestyle) from 14 international competitions between 2010-2018 were analysed. Individual 200-m freestyle season best time for the same year was located for each swimmer. Linear regression and machine learning was applied to 4 x 200-m swimming freestyle relay events. RESULTS: Compared to the individual event, the lowest ranked swimmer in the team (-0.62 s, CI = [-0.94, -0.30]) and American swimmers (-0.48 s [-0.89, -0.08]) typically swam faster 200-m times in relay events. Random forest models predicted gold, silver, bronze and non-medal with 100%, up to 41%, up to 63%, and 93% sensitivity, respectively. DISCUSSION: Team finishing position was strongly associated with the differential time to the fastest team (mean decrease in Gini (MDG) when this variable was omitted = 31.3), world rankings of team members (average ranking MDG of 18.9), and the order of swimmers (MDG = 6.9). Differential times are based on the sum of individual swimmer's season's best times, and along with world rankings, reflect team strength. In contrast, the order of swimmers reflects strategy. This type of analysis could assist coaches and support staff in selecting swimmers and team orders for relay events to enhance the likelihood of success.


Subject(s)
Competitive Behavior , Swimming , Athletic Performance
12.
PLoS One ; 16(6): e0251723, 2021.
Article in English | MEDLINE | ID: mdl-34061858

ABSTRACT

Peer-grouping is used in many sectors for organisational learning, policy implementation, and benchmarking. Clustering provides a statistical, data-driven method for constructing meaningful peer groups, but peer groups must be compatible with business constraints such as size and stability considerations. Additionally, statistical peer groups are constructed from many different variables, and can be difficult to understand, especially for non-statistical audiences. We developed methodology to apply business constraints to clustering solutions and allow the decision-maker to choose the balance between statistical goodness-of-fit and conformity to business constraints. Several tools were utilised to identify complex distinguishing features in peer groups, and a number of visualisations are developed to explain high-dimensional clusters for non-statistical audiences. In a case study where peer group size was required to be small (≤ 100 members), we applied constrained clustering to a noisy high-dimensional data-set over two subsequent years, ensuring that the clusters were sufficiently stable between years. Our approach not only satisfied clustering constraints on the test data, but maintained an almost monotonic negative relationship between goodness-of-fit and stability between subsequent years. We demonstrated in the context of the case study how distinguishing features between clusters can be communicated clearly to different stakeholders with substantial and limited statistical knowledge.


Subject(s)
Learning , Peer Group , Benchmarking , Cluster Analysis , Humans
13.
JAMA Neurol ; 78(6): 687-698, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33818600

ABSTRACT

Importance: Many patients with diabetic peripheral neuropathy experience chronic pain and inadequate relief despite best available medical treatments. Objective: To determine whether 10-kHz spinal cord stimulation (SCS) improves outcomes for patients with refractory painful diabetic neuropathy (PDN). Design, Setting, and Participants: The prospective, multicenter, open-label SENZA-PDN randomized clinical trial compared conventional medical management (CMM) with 10-kHz SCS plus CMM. Participants with PDN for 1 year or more refractory to gabapentinoids and at least 1 other analgesic class, lower limb pain intensity of 5 cm or more on a 10-cm visual analogue scale (VAS), body mass index (calculated as weight in kilograms divided by height in meters squared) of 45 or less, hemoglobin A1c (HbA1c) of 10% or less, daily morphine equivalents of 120 mg or less, and medically appropriate for the procedure were recruited from clinic patient populations and digital advertising. Participants were enrolled from multiple sites across the US, including academic centers and community pain clinics, between August 2017 and August 2019 with 6-month follow-up and optional crossover at 6 months. Screening 430 patients resulted in 214 who were excluded or declined participation and 216 who were randomized. At 6-month follow-up, 187 patients were evaluated. Interventions: Implanted medical device delivering 10-kHz SCS. Main Outcomes and Measures: The prespecified primary end point was percentage of participants with 50% pain relief or more on VAS without worsening of baseline neurological deficits at 3 months. Secondary end points were tested hierarchically, as prespecified in the analysis plan. Measures included pain VAS, neurological examination, health-related quality of life (EuroQol Five-Dimension questionnaire), and HbA1c over 6 months. Results: Of 216 randomized patients, 136 (63.0%) were male, and the mean (SD) age was 60.8 (10.7) years. Additionally, the median (interquartile range) duration of diabetes and peripheral neuropathy were 10.9 (6.3-16.4) years and 5.6 (3.0-10.1) years, respectively. The primary end point assessed in the intention-to-treat population was met by 5 of 94 patients in the CMM group (5%) and 75 of 95 patients in the 10-kHz SCS plus CMM group (79%; difference, 73.6%; 95% CI, 64.2-83.0; P < .001). Infections requiring device explant occurred in 2 patients in the 10-kHz SCS plus CMM group (2%). For the CMM group, the mean pain VAS score was 7.0 cm (95% CI, 6.7-7.3) at baseline and 6.9 cm (95% CI, 6.5-7.3) at 6 months. For the 10-kHz SCS plus CMM group, the mean pain VAS score was 7.6 cm (95% CI, 7.3-7.9) at baseline and 1.7 cm (95% CI, 1.3-2.1) at 6 months. Investigators observed neurological examination improvements for 3 of 92 patients in the CMM group (3%) and 52 of 84 in the 10-kHz SCS plus CMM group (62%) at 6 months (difference, 58.6%; 95% CI, 47.6-69.6; P < .001). Conclusions and Relevance: Substantial pain relief and improved health-related quality of life sustained over 6 months demonstrates 10-kHz SCS can safely and effectively treat patients with refractory PDN. Trial Registration: ClincalTrials.gov Identifier: NCT03228420.


Subject(s)
Diabetic Neuropathies/diagnosis , Diabetic Neuropathies/therapy , Pain Management/methods , Pain Measurement/methods , Spinal Cord Stimulation/methods , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
14.
J Pain Res ; 13: 2837-2851, 2020.
Article in English | MEDLINE | ID: mdl-33204145

ABSTRACT

BACKGROUND: Chronic upper extremity pain (UEP) has complex etiologies and is often disabling. It has been shown that 10 kHz SCS can provide paresthesia-free and durable pain relief in multiple pain types and improve the quality of life of patients. OBJECTIVE: To gain additional evidence on the safety and effectiveness of 10 kHz SCS for the treatment of chronic UEP. STUDY DESIGN: It was a prospective, multicenter, and observational study. The study was registered on ClinicalTrials.gov prospectively (clinical trial identifier: NCT02703818). SETTING: Multicenter. PATIENTS INTERVENTION AND MAIN OUTCOMES: A total of 43 subjects with chronic UEP of ≥5 cm (on a 0-10 cm visual analog scale; VAS) underwent a trial of 10 kHz SCS, and subjects with ≥40% pain relief received a permanent implant. All subjects had upper limb pain at baseline, while some had concomitant shoulder or neck pain. Subject outcomes were assessed for 12 months, and the primary outcome was the responder rate (percentage of subjects experiencing ≥50% pain relief from baseline) at three months. RESULTS: Thirty-eight subjects successfully completed the trial (88.3% success rate), 33 received permanent implants (five withdrew consent), and 32 had device activation (per protocol population). There were no paresthesias or uncomfortable changes in stimulation related to changes in posture during the study and there were no neurological deficits. Responder rates at 12 months for upper limb, shoulder, and neck pain in per protocol population (N=32) were 78.1%, 85.2%, and 75.0%, respectively. At 12 months, 84.4% of subjects were satisfied or very satisfied with 10 kHz SCS, and 38.7% either reduced or eliminated opioid usage. CONCLUSION: This study further supports the effectiveness of 10 kHz SCS for chronic UEP treatment and documents the safety profile of the therapy. CLINICAL TRIAL IDENTIFIER: NCT02703818.

15.
J Sports Sci ; 38(8): 886-896, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32122274

ABSTRACT

Spatio-temporal data in sport is increasing rapidly, however suitable statistical methods for analysing this data are underdeveloped. The current study establishes the need for spatial statistical methods, propose a Bayesian hierarchical model as an appropriate method for comparing spatial variables, and test this model across three spatial scales. The need for spatial statistical methods was established through the identification of spatial autocorrelation. This necessitated the use of a Bayesian hierarchical model to test for an association between spatial ball movement entropy and spatial effectiveness. Posterior distribution results showed a generally positive association such that increases in entropy were associated with increases in effectiveness. The strength and confidence of the associations were impacted by the spatial scale, with the 6 × 6 grid showing the most conclusive evidence of a positive relationship; the 4 × 4 grid was mostly positive, however with a large variation; and finally, the basket-centric scale results were less conclusive. The results of the current study demonstrate the suitability of a Bayesian hierarchical model for testing for associations or differences between spatial variables. With the increase in spatial analyses in sport, this study presents an appropriate statistical method for dealing with complex problems associated with spatial analyses.


Subject(s)
Basketball/physiology , Basketball/statistics & numerical data , Bayes Theorem , Entropy , Female , Humans , Movement , Spatial Analysis , Sports Equipment
16.
Biotechnol Prog ; 36(4): e2978, 2020 07.
Article in English | MEDLINE | ID: mdl-32034880

ABSTRACT

During the development of cell lines for therapeutic protein production, a vector harboring a product transgene is integrated into the genome. To ensure production stability and consistent product quality, single-cell cloning is then performed. Since cells derived from the same parental clone have the same transgene integration locus, the identity of the integration site can also be used to verify the clonality of a production cell line. In this study, we present a high-throughput pipeline for clonality verification through integration site analysis. Sequence capture of genomic fragments that contain both vector and host cell genome sequences was used followed by next-generation sequencing to sequence the relevant vector-genome junctions. A Python algorithm was then developed for integration site identification and validated using a cell line with known integration sites. Using this system, we identified the integration sites of the host vector for 31 clonal cell lines from five independent vector integration events while using one set of probes against common features of the host vector for transgene integration. Cell lines from the same lineage had common integration sites, and they were distinct from unrelated cell lines. The integration sites obtained for each clone as part of the analysis may also be used for clone selection, as the sites can have a profound effect on the transgene's transcript level and the stability of the resulting cell line. This method thus provides a rapid system for integration site identification and clonality verification.


Subject(s)
Cell Line/cytology , Clonal Evolution/genetics , Protein Biosynthesis/genetics , Proteins/therapeutic use , Algorithms , Animals , Cell Lineage/genetics , Genome/genetics , High-Throughput Nucleotide Sequencing , Humans , Proteins/genetics , Single-Cell Analysis
17.
PDA J Pharm Sci Technol ; 74(2): 264-274, 2020.
Article in English | MEDLINE | ID: mdl-31519780

ABSTRACT

The bioprocessing industry uses recombinant mammalian cell lines to generate therapeutic biologic drugs. To ensure consistent product quality of the therapeutic proteins, it is imperative to have a controlled production process. Regulatory agencies and the biotechnology industry consider cell line "clonal origin" an important aspect of maintaining process control. Demonstration of clonal origin of the cell substrate, or production cell line, has received considerable attention in the past few years, and the industry has improved methods and devised standards to increase the probability and/or assurance of clonal derivation. However, older production cell lines developed before the implementation of these methods, herein referred to as "legacy cell lines," may not meet current regulatory expectations for demonstration of clonal derivation. In this article, the members of the IQ Consortium Working Group on Clonality present our position that the demonstration of process consistency and product comparability of critical quality attributes throughout the development life cycle should be sufficient to approve a license application without additional genetic analysis to support clonal origin, even for legacy cell lines that may not meet current day clonal derivation standards. With this commentary, we discuss advantages and limitations of genetic testing methods to support clonal derivation of legacy cell lines and wish to promote a mutual understanding with the regulatory authorities regarding their optional use during early drug development, subsequent to Investigational New Drug (IND) application and before demonstration of product and process consistency at Biologics License Applications (BLA) submission.


Subject(s)
Biological Products/chemical synthesis , Biological Products/pharmacology , Drug Development/methods , Genetic Testing/methods , Whole Genome Sequencing/methods , Animals , CHO Cells , Cell Line , Cricetinae , Cricetulus , Drug Development/standards , Genetic Testing/standards , Program Development/methods , Program Development/standards , Whole Genome Sequencing/standards
18.
PLoS One ; 14(7): e0219295, 2019.
Article in English | MEDLINE | ID: mdl-31291303

ABSTRACT

PURPOSE: This study investigated the relationship between the ground reaction force-time profile of a countermovement jump (CMJ) and fatigue, specifically focusing on predicting the onset of neuromuscular versus metabolic fatigue using the CMJ. METHOD: Ten recreational athletes performed 5 CMJs at time points prior to, immediately following, and at 0.5, 1, 3, 6, 24 and 48 h after training, which comprised repeated sprint sessions of low, moderate, or high workloads. Features of the concentric portion of the CMJ force-time signature at the measurement time points were analysed using Principal Components Analysis (PCA) and functional PCA (fPCA) to better understand fatigue onset given training workload. In addition, Linear Mixed Effects (LME) models were developed to predict the onset of fatigue. RESULTS: The first two Principal Components (PCs) using PCA explained 68% of the variation in CMJ features, capturing variation between athletes through weighted combinations of force, concentric time and power. The next two PCs explained 9.9% of the variation and revealed fatigue effects between 6 to 48 h after training for PC3, and contrasting neuromuscular and metabolic fatigue effects in PC4. fPCA supported these findings and further revealed contrasts between metabolic and neuromuscular fatigue effects in the first and second half of the force-time curve in PC3, and a double peak effect in PC4. Subsequently, CMJ measurements up to 0.5 h after training were used to predict relative peak CMJ force, with mean squared errors of 0.013 and 0.015 at 6 and 48 h corresponding to metabolic and neuromuscular fatigue. CONCLUSION: The CMJ was found to provide a strong predictor of neuromuscular and metabolic fatigue, after accounting for force, concentric time and power. This method can be used to assist coaches to individualise future training based on CMJ response to the immediate session.


Subject(s)
Athletic Performance/physiology , Football/physiology , Muscle Fatigue/physiology , Muscle Strength/physiology , Adult , Athletes , Exercise Test , Humans , Male , Neuromuscular Monitoring/methods , Plyometric Exercise , Principal Component Analysis , Young Adult
19.
Int J Sports Physiol Perform ; 14(7): 966-971, 2019 07 01.
Article in English | MEDLINE | ID: mdl-30676830

ABSTRACT

PURPOSE: Critical speed (CS) and supra-CS distance capacity (D') are useful metrics for monitoring changes in swimmers' physiological and performance capacities. However, the utility of these metrics across a season has not been systematically evaluated in high level swimmers. METHODS: Twenty-seven swimmers (18 female; age 19.1 ± 2.9 y, 9 male; 19.5 ± 1.9 y, mean ± SD) completed the 12x25m swimming test multiple times (4 ± 3 tests/swimmer) across a two-year period. Season-best times in all distances for the test stroke were sourced from publicly available databases. Swimmers' distance speciality was determined as the event with the time closest to world record. Four metrics were calculated from the 12x25m test: CS, D', peak speed and drop off %. RESULTS: Guyatt's Responsiveness Index values were calculated to ascertain the practically relevant sensitivity of each 12x25m metric: CS = 1.5, peak speed = 2.3, D' = 2.1 and drop off % = 2.6. These values are modified effect sizes (ES); all are large effects. Bayesian mixed-modelling showed substantial between-subject differences between genders and strokes for each variable, but minimal within-subject changes across the season. Drop off % was lower in 200 m swimmers (14.0 ± 3.3%) compared to 100 m swimmers (18.1 ± 4.1%, p = 0.003, ES = 1.10). CONCLUSION: The 12x25m test is best suited to differentiating between swimmers of different strokes and events. Further development is needed to improve its utility in quantifying meaningful changes over a season for individual swimmers.


Subject(s)
Athletic Performance/trends , Swimming/physiology , Time Factors , Adolescent , Bayes Theorem , Cross-Sectional Studies , Female , Humans , Longitudinal Studies , Male , Young Adult
20.
Nat Commun ; 8(1): 1263, 2017 11 02.
Article in English | MEDLINE | ID: mdl-29093493

ABSTRACT

Better mitigation of anthropogenic stressors on marine ecosystems is urgently needed to address increasing biodiversity losses worldwide. We explore opportunities for stressor mitigation using whole-of-systems modelling of ecological resilience, accounting for complex interactions between stressors, their timing and duration, background environmental conditions and biological processes. We then search for ecological windows, times when stressors minimally impact ecological resilience, defined here as risk, recovery and resistance. We show for 28 globally distributed seagrass meadows that stressor scheduling that exploits ecological windows for dredging campaigns can achieve up to a fourfold reduction in recovery time and 35% reduction in extinction risk. Although the timing and length of windows vary among sites to some degree, global trends indicate favourable windows in autumn and winter. Our results demonstrate that resilience is dynamic with respect to space, time and stressors, varying most strongly with: (i) the life history of the seagrass genus and (ii) the duration and timing of the impacting stress.


Subject(s)
Alismatales/physiology , Ecosystem , Oceans and Seas , Stress, Physiological/physiology , Bayes Theorem , Biodiversity , Ecology , Hydrocharitaceae/physiology , Time Factors , Zosteraceae/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...